Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 10Neoplasms 6Prostatic Neoplasms 5Anxiety Disorders 5Leukemia 4Uterine Cervical Neoplasms 3Stomach Neoplasms 3Ovarian Neoplasms 3Neoplasms, Plasma Cell 3Neoplasm Metastasis 3Multiple Myeloma 3Lymphoma 3Fatigue 3Depression 3Colorectal Neoplasms 3Rectal Neoplasms 2Primary Myelofibrosis 2Hodgkin Disease 2Hematologic Neoplasms 2Head and Neck Neoplasms 2Gastrointestinal Stromal Tumors 2Gastrointestinal Neoplasms 2Endometrial Neoplasms 2Colonic Neoplasms 2Anus Neoplasms 2cyclopia sequence 1Vulvar Neoplasms 1Vomiting 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1

Interventions

fludarabine phosphate 6Rituximab 5Antilymphocyte Serum 5Tacrolimus 4Cyclophosphamide 4pegaspargase 3Whole-Body Irradiation 3Radiotherapy, Intensity-Modulated 3Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Oxaliplatin 3Mycophenolic Acid 3Etoposide 3Dasatinib 3Vincristine 2Melphalan 2Lenalidomide 2Gemcitabine 2Filgrastim 2Doxorubicin 2Busulfan 2tislelizumab 1thymoglobulin 1tanespimycin 1plerixafor 1pegylated granulocyte colony-stimulating factor, human 1pegfilgrastim 1obatoclax 1gemcitabine-oxaliplatin regimen 1etoposide phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Lymphoma, Extranodal NK-T-Cell × Surveys and Questionnaires × Clear all
NCT02392039 2019-04-23

Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Terminated
1 enrolled
Lymphoid

Burkitt Lymphoma, Lymphoma, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡